Insulin glargine/lixisenatide fixed-ratio combination (iGlarLixi) compared with premix or addition of meal-time insulin to basal insulin in people with type 2 diabetes: A systematic review and Bayesian network meta-analysis - Home, P; Blonde, L; Kalra, S (Diabetes Obes Metab, 2020)